AGE studie
Recruiting
- Conditions
- H, embryo quality, IVF, live birth rate
- Registration Number
- NL-OMON21944
- Lead Sponsor
- MerckSerono
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 220
Inclusion Criteria
1. Patients between 35 and 43 years of age
2. Patients with IOF, <35 years
Exclusion Criteria
Endocrinopathological disease as: Cushing’s syndrome, adrenal hyperplasia, hyperprolactinaemia, acromegaly, hypothalamic amenorrhea, hypothyroidy, diabetes mellitus type I, PCOS
If not willing or able to sign the informed consent form
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percentage of top-quality embryos
- Secondary Outcome Measures
Name Time Method - Number of follicles > 14 mm on hCG day<br /><br>- Number of retrieved oocytes<br /><br>- Number of metaphase II oocytes<br /><br>- Pronuclear morphology <br /><br>- Total number of embryos <br /><br>- Presence of early cleavage <br /><br>- Cleavage stage morphology<br /><br>- Number of embryos suitable for transfer<br /><br>- Biochemical, clinical, ongoing pregnancies<br /><br>- Live-birth rate<br /><br>